Evidence-Based Management of Anticoagulant TherapyAnne Holbrook, Gordon Guyatt, Sam Schulman et al.|CHEST Journal|2012Cited by 1.3k
Andexanet Alfa for the Reversal of Factor Xa Inhibitor ActivityDeborah Siegal, Mark Crowther, Janet M. Leeds et al.|New England Journal of Medicine|2015Cited by 1k
Treatment and Prevention of Heparin-Induced ThrombocytopeniaLori‐Ann Linkins, Mark Crowther, Antonio L. Dans et al.|CHEST Journal|2012Cited by 1k
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J. Connolly, Truman J. Milling, Mark Crowther et al.|New England Journal of Medicine|2019Cited by 945
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated CoagulopathyJean‐Louis Vincent, Bruno François, И. Б. Заболотских et al.|JAMA|2019Cited by 370